Home LiteratureArticle Details
PMID: 15155225 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans.

Antimicrobial agents and chemotherapy ·Vol. 48 ·No. 6 ·2004-06-00 ·Pages 2223-7

Dodgson AR, Dodgson KJ, Pujol C, Pfaller MA, Soll DR

Abstract

Population studies have indicated that natural resistance to flucytosine (5FC) in Candida albicans is limited to one of the five major clades, clade I. In addition, while 73% of clade I isolates are less susceptible to 5FC (MIC >/= 0.5 microg/ml), only 2% of non-clade I isolates are less susceptible. In order to determine the genetic basis for this clade-specific resistance, we sequenced two genes involved in the metabolism of 5FC that had previously been linked to resistance (cytosine deaminase and uracil phosphoribosyltransferase), in 48 isolates representative of all clades. Our results demonstrate that a single nucleotide change from cytosine to thymine at position 301 in the uracil phosphoribosyltransferase gene (FUR1) of C. albicans is responsible for 5FC resistance. The mutant allele was found only in group I isolates. The 5FC MICs for strains without copies of the mutant allele were almost exclusively </=0.25 microg/ml, those for strains with one copy of the mutant allele were >/=0.5 microg/ml, and those for strains with two copies of the mutant allele were >/=16 microg/ml. Thus, the two alleles were codominant. The presence of this allele is responsible for clade I-specific resistance to 5FC within the C. albicans population and thus by inference is likely to be the major underlying 5FC resistance mechanism in C. albicans. This represents the first description of the genetic mutation responsible for 5FC resistance.

MeSH Terms
Amino Acid Sequence Antifungal Agents/pharmacology Arginine/physiology Candida albicans/drug effects,genetics Cysteine/physiology DNA Fingerprinting Drug Resistance, Fungal/genetics Flucytosine/pharmacology Genes, Fungal/genetics Genotype Microbial Sensitivity Tests Molecular Sequence Data Mutation/genetics,physiology Nucleotides/genetics Reverse Transcriptase Polymerase Chain Reaction
Chemicals
Antifungal Agents Nucleotides Arginine Flucytosine Cysteine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Dodgson Andrew R
Department of Biological Sciences, 302 BBE, The University of Iowa, Iowa City, IA 52242, USA.
Dodgson Kirsty J
Pujol Claude
Pfaller Michael A
Soll David R
References (25)
25 references, click to expand
  1. White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating.
    Cell. 2002 Aug 9;110(3):293-302 PMID: 12176317
  2. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.
    J Clin Microbiol. 1997 Sep;35(9):2348-58 PMID: 9276415
  3. Cell biology of mating in Candida albicans.
    Eukaryot Cell. 2003 Feb;2(1):49-61 PMID: 12582122
  4. Skin facilitates Candida albicans mating.
    Infect Immun. 2003 Sep;71(9):4970-6 PMID: 12933839
  5. Candida albicans clades.
    FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):1-7 PMID: 14556989
  6. Flucytosine resistance is restricted to a single genetic clade of Candida albicans.
    Antimicrob Agents Chemother. 2004 Jan;48(1):262-6 PMID: 14693548
  7. Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae.
    J Bacteriol. 1970 Jun;102(3):607-15 PMID: 5429721
  8. Evidence for a common transport system for cytosine, adenine and hypoxanthine in Saccharomyces cerevisiae and Candida albicans.
    Eur J Biochem. 1973 Jan 15;32(2):276-82 PMID: 4569075
  9. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
    Antimicrob Agents Chemother. 1972 Sep;2(3):114-21 PMID: 4597703
  10. Mode of action of 5-fluorocytosine and mechanisms of resistance.
    Chemotherapy. 1975;21(3-4):113-30 PMID: 1098864
  11. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates.
    Antimicrob Agents Chemother. 1982 Nov;22(5):810-5 PMID: 6758690
  12. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans.
    Antimicrob Agents Chemother. 1984 Oct;26(4):570-4 PMID: 6393861
  13. Application of DNA typing methods to epidemiology and taxonomy of Candida species.
    J Clin Microbiol. 1987 Apr;25(4):675-9 PMID: 3033016
  14. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.
    Clin Microbiol Rev. 1998 Apr;11(2):382-402 PMID: 9564569
  15. Crystal structures of Toxoplasma gondii uracil phosphoribosyltransferase reveal the atomic basis of pyrimidine discrimination and prodrug binding.
    EMBO J. 1998 Jun 15;17(12):3219-32 PMID: 9628859
  16. Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans.
    Science. 1999 Aug 20;285(5431):1271-5 PMID: 10455055
  17. Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host.
    Science. 2000 Jul 14;289(5477):307-10 PMID: 10894780
  18. Induction of mating in Candida albicans by construction of MTLa and MTLalpha strains.
    Science. 2000 Jul 14;289(5477):310-3 PMID: 10894781
  19. Flucytosine primary resistance in Candida species and Cryptococcus neoformans.
    Eur J Clin Microbiol Infect Dis. 2001 Apr;20(4):276-9 PMID: 11399020
  20. Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa.
    J Clin Microbiol. 2002 Mar;40(3):826-36 PMID: 11880401
  21. Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South America, and Europe reveals a European clade.
    J Clin Microbiol. 2002 Aug;40(8):2729-40 PMID: 12149321
  22. The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients.
    Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9456-9 PMID: 8415722
  23. Molecular markers reveal that population structure of the human pathogen Candida albicans exhibits both clonality and recombination.
    Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12473-7 PMID: 8901606
  24. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
    Clin Infect Dis. 1997 Feb;24(2):235-47 PMID: 9114154
  25. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.
    Antimicrob Agents Chemother. 2002 Nov;46(11):3518-21 PMID: 12384359
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
2004-06-00
Pages
2223-7
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC415630
Subset
IM
Grants
NIAID NIH HHS · R01 AI039735 · United States
NIAID NIH HHS · AI39735 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]